National Taiwan University    |     NTU, College of Medicine
NTU, Department of Pharmacy
Graduate Institute of Clinical Pharmacy
Bachelor's Degree Program in Biotechnology and Pharmaceutical Sciences
Drug Research Center
Ching Kang Foundation
Center for Innovative Therapeutics Discovery
NTUH,Department of Pharmacy
Taiwan Society of Health-System Pharmacists
Alumni    |     Alumni in North America    |     AASP
Instrumentation Booking System
Platform for Research and Inspiration in Regulatory Science
© copyright 2014 SP, NTU. All Rights Reserved.
No.33, Linsen S. Rd., Zhongzheng Dist., Taipei City 100025, Taiwan (R.O.C.)
TEL : (02)3366-8750~4    FAX : (02)2391-9098
Web person in charge: Tang-Yih Hsu
Contact Phone : (02)33668743
Latest Update : 2026 / 05 / 15
Privacy & Security Policy | Information security
Faculty
back
Wan-Tseng Hsu
Title:Associate Professor
TEL:+886-2-33668195     Email:wantsenghsu@ntu.edu.tw
NTU SCHOLAR
Personal Website
PortfolioPortfolio ResearchResearch
Published:
Posters & Speeches:Subjects:Amphiregulin and Inducible Nitric Oxide Synthase Non-redundantly Regulate Butyrate-Induced Enhanced Immunomodulation of Adipose-Derived Stem Cells (2017)
Speakers:Wan-Tseng Hsu
Address:International Cytokine and Interferon Society, Cytokines 2017, Kanazawa, Japan

Subjects:Transition of Pharmacy Education from Bachelor of Science to Doctor of Pharmacy Impacts Student Career Path for Pharmacy Professionals in Taiwan. (2018)
Speakers:Tsun-Yu Yang, Wan-Tseng Hsu
Address:IPSF World Congress 2018, Mendoza, Argentina.

Subjects:A Protocol-driven Heart Failure Clinic Staffed by Pharmacist Specialists with an Interactive Mobile Phone–Website Platform (2019)
Speakers:Wan-Tseng Hsu
Address:The 49th Annual Convention & Scientific Session of the Taiwan Society of Cardiology, Taipei, Taiwan

Research Projects:Subject:Develop an adipose-derived stem cell-based approach for the immunomodulation of obesity-induced metaflammation through butyrate regulation
Duration:2017-12 ~ 2018-10
Principal Investigator:Wan-Tseng Hsu

Subject:A step toward reversing the rapid emergence of young female breast cancer in Taiwan
Duration:0110-08 ~ 0111-07

Subject:Screen of FDA-approved bioactive compounds to prime adiposederived stem cells for enhanced immunomodulation and attenuated mitochondrial bioenergetics in a spontaneous mouse model of metabolic syndrome
Duration:2018-08 ~ 2019-07

Subject:Explore melatonin as a therapeutic strategy to prime adipose-derived stem cells for enhanced immunomodulation in a spontaneous mouse model of metabolic syndrome
Duration:2019-01 ~ 2019-12
Principal Investigator:Wan-Tseng Hsu

Subject:Develop an adipose-derived stem cell-based approach for the immunomodulation of metabolic syndrome-induced adipose tissue inflammation and cardiac dysfunction through butyrate regulation
Duration:2019-08 ~ 2020-07
Principal Investigator:Wan-Tseng Hsu

Subject:心衰竭合併貧血病人之檢查現狀與治療分析
Duration:2020-01 ~ 2020-12